Find DUPIXENT® (dupilumab) injection videos and instructions for the pre-filled syringe (200 mg or 300 mg) with needle shield for ages 6 months & older. DUPIXENT® (dupilumab) is a prescription medicine FDA-approved to treat six conditions.

Find videos and downloadable instructions for the two injection administration options available for DUPIXENT® (dupilumab), pre-filled syringe (200 mg or 300 mg) with needle shield for ages 6 months & older, or pre-filled pen (200 mg or 300 mg) for ages 2+ years.

It contains 300 mg of DUPIXENT for injection under the skin (subcutaneous injection). Read all of the instructions carefully before using the DUPIXENT Syringe. Ask your healthcare provider how often you will need to inject the medicine.

Each 300 mg pre-filled syringe or pre-filled pen delivers 300 mg/2 mL. Each 200 mg pre-filled syringe or pre-filled pen delivers 200 mg/1.14 mL. DUPIXENT is sterile and preservative-free. Patients and/or caregivers should discard any unused portion.

This DUPIXENT Pre-filled Pen is a single-dose device. It contains 300 mg of DUPIXENT for injection under the skin (subcutaneous injection). Read all of the instructions carefully before using the DUPIXENT Pre-filled Pen. Ask your healthcare provider how often you will need to …

Learn about DUPIXENT® (dupilumab) dosage and administration for inadequately controlled COPD (chronic obstructive pulmonary disease) and an eosinophilic phenotype in appropriate patients aged 18+ years. Available in two options, pre-filled syringe & pre-filled pen (300mg). Serious adverse reactions may occur.

In children less than 12 years of age, DUPIXENT should be given by a caregiver. This device is a Single-use Pre-filled Syringe (called “Syringe” in these instructions) with a needle shield. It contains 300 mg of DUPIXENT for injection under the skin (subcutaneous injection). Keep these instructions for future use.

DUPIXENT is an interleukin-4 receptor alpha antagonist indicated: . Atopic Dermatitis . for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe AD whose...

Jan 13, 2025 · The recommended Dupixent dosage for adults and children aged 12 and older for chronic rhinosinusitis with nasal polyps is Dupixent 300 mg given every other week (Q2W). Dupixent for EoE (eosinophilic esophagitis)

Oct 1, 2024 · Dupixent is available in the following dosage forms that are injected under the skin (subcutaneous). 300 mg/2 mL (150 mg/mL) solution for injection, single-dose pre-filled syringe or pen